36C24426F0063↗

Name: 36C24426F0063: Radiopharmaceuticals-Lutathera and Pluvicto Injections
Creator: SpendQuery
License: https://creativecommons.org/licenses/by/4.0/

Novartis Pharmaceuticals Corporation received this contract from 244-Network Contract Office 4 (36C244), Department of Veterans Affairs: $1.98M obligated so far for drugs and biologicals. It runs to 2026-12-31.

Key facts · data as of Oct 22, 2026

Recipient: Novartis Pharmaceuticals Corporation
Awarding agency: Department of Veterans Affairs
Contracting office: 244-Network Contract Office 4 (36C244) (36C244)
Obligated to date: $1.98M
Potential value: $1.98M
Ends: 2026-12-31

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 22, 2026.

Cite this page: SpendQuery, Award 36C24426F0063, data as of Oct 22, 2026, https://spendquery.com/award?id=CONT_AWD_36C24426F0063_3600_36F79720D0180_3600

Novartis Pharmaceuticals Corporation: all federal awards · Department of Veterans Affairs: spending · 244-Network Contract Office 4 (36C244): what it buys · The follow-on: recompete brief

RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS

Delivery Order · Department of Veterans Affairs · to Novartis Pharmaceuticals Corporation (UEI NG61ZA8TADW3) · data as of 2026-10-22

Obligated to date$1.98M1 action

Current value$1.98Mwith options exercised

Period2026-01-01 → 2026-12-31current end date

Up for re-bid: ends 2026-12-31. Recompete brief → · 6505--Lab Supplies - Radiopharm Philadelphia VA Medical Center ↗

What it is

Product or service: Drugs and Biologicals (PSC 6505)
Industry: Pharmaceutical Preparation Manufacturing (NAICS 325412)
Contracting office: 244-Network Contract Office 4 (36C244) (36C244)
Competition: Full and open competition · 1 offer received
Pricing: Firm fixed price
How it was bought: GSA Schedule · under 36F79720D0180
Where the work is: Lebanon, PA · district PA-09

Obligations by fiscal year

FY2026$1.98M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2025-12-19. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2025-12-19	0		$1.98M	RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗